Related Experiment Videos
Sentinel node localization in primary melanoma: learning curve and results
A Testori1, M Bartolomei, C Grana
1Division of Surgical Oncology, European Institute of Oncology, Milan, Italy. atestori@ieo.it
Melanoma Research
|February 8, 2000
Summary
Simultaneously using patent blue dye (PBD) and lymphoscintigraphy with a gamma probe significantly improves sentinel node (SN) detection in melanoma patients, reducing procedure failures.
Area of Science:
- Oncology
- Surgical Innovation
- Nuclear Medicine
Background:
- Sentinel node biopsy is crucial for melanoma staging.
- Accurate sentinel node identification impacts treatment decisions.
- Existing methods for sentinel node localization have limitations.
Purpose of the Study:
- To evaluate the combined efficacy of patent blue dye (PBD) and lymphoscintigraphy with a gamma detection probe for sentinel node (SN) localization.
- To assess the learning curve associated with these techniques.
- To analyze the procedural time for SN identification.
Main Methods:
- Ninety primary melanoma patients were studied.
- Preoperative lymphoscintigraphy visualized SNs.
- Intraoperative identification used PBD and a gamma detection probe.
- Radioactivity and color of identified SNs were documented.
Main Results:
- Combined PBD and gamma probe detected 98.5% of SNs, surpassing individual method efficacy (PBD: 78.52%, gamma probe: 95.5%).
- A learning curve was observed for PBD, but not for the gamma probe.
- Procedure time was significantly shorter for PBD-identified SNs.
Conclusions:
- Simultaneous use of PBD and gamma probe offers superior SN detection rates in melanoma.
- Collaborative efforts between surgeons and nuclear medicine physicians are recommended.
- This combined approach minimizes procedure failures and enhances staging accuracy.